Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Urologic Endoscopic Procedure: Cystoscopic Examination01:28

Urologic Endoscopic Procedure: Cystoscopic Examination

2.3K
Meaning of Cystoscopic Examination:Cystoscopy is an essential diagnostic tool in urology that is used to assess the structure and function of the genitourinary system. It provides a direct view of the urethra, bladder, and, in some cases, the ureteral openings. This procedure helps detect structural abnormalities, infections, cancers, and blockages in the urinary tract. There are two types of cystoscopy:Flexible cystoscopy is commonly performed in outpatient settings due to its less invasive...
2.3K
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

4.0K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
4.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Management of Persistent Storage Symptoms and Overactive Bladder in Men Diagnosed with Benign Prostatic Hyperplasia: A Narrative Review.

Advances in therapy·2026
Same author

Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline (2026) Part III: Procedural/Surgical Management.

The Journal of urology·2026
Same author

Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline (2026) Part II: Medical Management.

The Journal of urology·2026
Same author

Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline (2026) Part I: Presentation and Evaluation.

The Journal of urology·2026
Same author

Urinary Fungal Microbiome and Associations With Overactive Bladder, Antibiotics and Therapy Response.

Neurourology and urodynamics·2026
Same author

Urinary Microbiome and Metabolome Differentiate Overactive Bladder From the Physiological State, and Reflect Recent Antibiotic Use and Treatment Response.

The Journal of urology·2026

Related Experiment Video

Updated: Jan 14, 2026

Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate HoLEP.
06:04

Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate HoLEP.

Published on: March 6, 2018

17.5K

Benign Prostatic Hyperplasia Procedures in Patients with Prostate Cancer:: What Do We Know?

Jason M Scovell1, Saveliy Kelebeyev1, Michael D Gross1

  • 1Department of Urology, Glickman Urological Institute, Cleveland Clinic.

The Urologic Clinics of North America
|October 17, 2025
PubMed
Summary

Benign prostatic hyperplasia (BPH) and prostate cancer (PCa) often coexist. This review examines BPH treatments for men with PCa, emphasizing shared decision-making for symptom relief and cancer control.

Keywords:
Active surveillanceBenign prostatic hyperplasiaMinimally invasive therapyProstateProstate cancerQuality of lifeTransurethral resectionUrinary retention

More Related Videos

Enucleation of the Prostate for the Treatment of Benign Prostatic Hyperplasia Using a 980 nm Diode Laser
05:28

Enucleation of the Prostate for the Treatment of Benign Prostatic Hyperplasia Using a 980 nm Diode Laser

Published on: May 5, 2020

2.6K
Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser
07:17

Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser

Published on: May 9, 2018

8.4K

Related Experiment Videos

Last Updated: Jan 14, 2026

Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate HoLEP.
06:04

Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate HoLEP.

Published on: March 6, 2018

17.5K
Enucleation of the Prostate for the Treatment of Benign Prostatic Hyperplasia Using a 980 nm Diode Laser
05:28

Enucleation of the Prostate for the Treatment of Benign Prostatic Hyperplasia Using a 980 nm Diode Laser

Published on: May 5, 2020

2.6K
Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser
07:17

Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser

Published on: May 9, 2018

8.4K

Area of Science:

  • Urology
  • Oncology

Background:

  • Benign prostatic hyperplasia (BPH) and prostate cancer (PCa) frequently coexist in aging men.
  • This overlap presents complex clinical management challenges.

Purpose of the Study:

  • To review surgical and minimally invasive BPH therapies in patients with concurrent PCa.
  • To evaluate treatment efficacy, complications, and oncological outcomes.
  • To guide clinical decision-making for optimal patient care.

Main Methods:

  • Literature review of BPH treatments in the context of PCa.
  • Analysis of efficacy, complications, and oncological implications.
  • Discussion of treatment strategies for patients on active surveillance or radiation therapy.

Main Results:

  • Various BPH therapies can be adapted for men with PCa.
  • Careful consideration of efficacy, complications, and oncological impact is crucial.
  • Shared decision-making and a multidisciplinary approach are essential.

Conclusions:

  • Treatment selection for BPH in PCa patients requires a personalized, multidisciplinary strategy.
  • Balancing symptom relief with cancer control is paramount.
  • Further research is needed to optimize long-term outcomes.